The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The price of Caredx Inc (NASDAQ: CDNA) closed at $23.34 in the last session, down -1.31% from day before closing price of $23.65. In other words, the price has decreased by -$1.31 from its previous closing price. On the day, 0.93 million shares were traded. CDNA stock price reached its highest trading level at $24.9 during the session, while it also had its lowest trading level at $23.2101.
Ratios:
We take a closer look at CDNA’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 5.15 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 1016.19. For the most recent quarter (mrq), Quick Ratio is recorded 3.87 and its Current Ratio is at 4.10. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Wells Fargo on August 28, 2024, initiated with a Underweight rating and assigned the stock a target price of $28.
On August 19, 2024, BTIG Research Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $40.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 20 ’24 when Johnson Alexander L sold 39,466 shares for $33.17 per share. The transaction valued at 1,309,087 led to the insider holds 284,983 shares of the business.
Johnson Alexander L sold 21,557 shares of CDNA for $702,327 on Aug 21 ’24. The insider now owns 284,983 shares after completing the transaction at $32.58 per share. On Aug 20 ’24, another insider, Maag Peter, who serves as the Director of the company, sold 35,552 shares for $33.04 each. As a result, the insider received 1,174,493 and left with 330,024 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CDNA now has a Market Capitalization of 1251815296 and an Enterprise Value of 1040926528. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.96 while its Price-to-Book (P/B) ratio in mrq is 4.54. Its current Enterprise Value per Revenue stands at 3.328 whereas that against EBITDA is -23.521.
Stock Price History:
Over the past 52 weeks, CDNA has reached a high of $34.84, while it has fallen to a 52-week low of $6.91. The 50-Day Moving Average of the stock is -13.96%, while the 200-Day Moving Average is calculated to be 31.56%.
Shares Statistics:
According to the various share statistics, CDNA traded on average about 895.82K shares per day over the past 3-months and 890680 shares per day over the past 10 days. A total of 51.50M shares are outstanding, with a floating share count of 50.19M. Insiders hold about 6.42% of the company’s shares, while institutions hold 91.31% stake in the company. Shares short for CDNA as of 1728950400 were 3476043 with a Short Ratio of 3.88, compared to 1726185600 on 3659670. Therefore, it implies a Short% of Shares Outstanding of 3476043 and a Short% of Float of 8.66.
